Sandra Patterson - Mar 10, 2025 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role: SVP, Controllership
Signature: /s/ Edward S. Son by Power of Attorney for Sandra C. Patterson
Stock symbol: GILD
Transactions as of: Mar 10, 2025
Transactions value $: -$73,139
Form type: 4
Date filed: 3/12/2025, 06:10 PM
Previous filing: Feb 6, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GILD	Common Stock	Options Exercise		+1.95K	+5.12%		40.1K	Mar 10, 2025	Direct	F1
transaction	GILD	Common Stock	Tax liability	-$73.1K	-624	-1.56%	$117.21	39.5K	Mar 10, 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GILD	Restricted Stock Unit	Options Exercise		-1.95K	-16.5%		9.88K	Mar 10, 2025	Common Stock	1.95K		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2	Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan.
F3	The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.